Top Industry Leaders in the Artificial Kidney Market
Latest Artificial Kidney Companies Update:
Oct 2023-Jan 2024
KidneyX (US) Launched a $10.5 million prize competition to incentivize development of a fully functional bioartificial kidney, showcasing growing public and private interest. Partnered with academic institutions to accelerate research and development in the field.
eGenesis (US) Received FDA approval for a Phase 2 clinical trial of their bioengineered human kidney implant, marking a significant milestone in xenotransplantation. Collaborated with medical centers to conduct the trial and bring this potential solution closer to patients.
Living Kidney Donor Matching System (LKDMS) Implemented AI-powered algorithms to improve kidney transplant matching and increase compatibility rates, offering hope for patients awaiting suitable donors. Collaborated with transplant centers to optimize organ allocation and expedite transplantation procedures.
Nestle Health Science (Switzerland) Focused on developing an artificial kidney based on biomimicry principles, replicating the natural functions of a healthy kidney for improved efficacy. Partnered with technology companies to leverage AI and advanced materials in their design.
University of California, San Francisco (UCSF) Developed a miniaturized artificial kidney prototype using microfluidic technology, offering a potentially wearable and portable solution for dialysis patients. Conducted preclinical studies to validate the technology and prepare for future clinical trials.
List of Artificial Kidney Key companies in the market
-
Kawasumi Laboratories Inc.
-
Blood Purification Technologies Inc.
-
AWAK Technologies Pte. Ltd
-
Trimmed AB
-
Asahi Kasei Medical Vo. Ltd
-
US Kidney Research Corporation
-
Merit Medical Systems
-
NIPRO Medical Corporation
-
Fresenius SE & Co. KGaA